Rao Vidya, Kumar Rajiv, Rajaganesan Sathyanarayanan, Rane Swapnil, Deshpande Gauri, Yadav Subhash, Patil Asawari, Pai Trupti, Menon Santosh, Shah Aekta, Rabade Katha, Ramadwar Mukta, Panjwani Poonam, Mittal Neha, Sahay Ayushi, Rekhi Bharat, Bal Munita, Sakhadeo Uma, Gujral Sumeet, Desai Sangeeta
Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
J Pathol Inform. 2021 Jan 8;12:3. doi: 10.4103/jpi.jpi_72_20. eCollection 2021.
The COVID-19 pandemic accelerated the widespread adoption of digital pathology (DP) for primary diagnosis in surgical pathology. This paradigm shift is likely to influence how we function routinely in the postpandemic era. We present learnings from early adoption of DP for a live digital sign-out from home in a risk-mitigated environment.
We aimed to validate DP for remote reporting from home in a real-time environment and evaluate the parameters influencing the efficiency of a digital workflow. Eighteen pathologists prospectively validated DP for remote use on 567 biopsy cases including 616 individual parts from 7 subspecialties over a duration from March 21, 2020, to June 30, 2020. The slides were digitized using Roche Ventana DP200 whole-slide scanner and reported from respective homes in a risk-mitigated environment.
Following re-review of glass slides, there was no major discordance and 1.2% ( = 7/567) minor discordance. The deferral rate was 4.5%. All pathologists reported from their respective homes from laptops with an average network speed of 20 megabits per second.
We successfully validated and adopted a digital workflow for remote reporting with available resources and were able to provide our patients, an undisrupted access to subspecialty expertise during these unprecedented times.
新型冠状病毒肺炎（COVID-19）大流行加速了数字病理学（DP）在外科病理学初步诊断中的广泛应用。这种模式转变可能会影响我们在疫情后时代的日常工作方式。我们介绍了在风险可控环境中早期采用DP进行居家实时数字诊断报告的经验。
我们旨在验证DP在实时环境中用于居家远程报告的有效性，并评估影响数字工作流程效率的参数。2020年3月21日至2020年6月30日期间，18名病理学家对567例活检病例（包括来自7个亚专业的616个独立部分）进行了前瞻性验证，以确定DP在远程使用中的有效性。使用罗氏Ventana DP200全切片扫描仪对玻片进行数字化处理，并在风险可控的环境中从各自家中进行报告。
重新检查玻片后，未发现重大不一致情况，轻微不一致率为1.2%（7/567）。延期率为4.5%。所有病理学家均通过平均网络速度为每秒20兆比特的笔记本电脑在各自家中进行报告。
我们成功地利用现有资源验证并采用了远程报告的数字工作流程，能够在这些前所未有的时期为患者提供不间断的亚专业专家服务。
